July 18, 2007

Post Zinger selected for NanoMed Pharmaceuticals

NanoMed Pharmaceuticals signed Room 214 to integrate Post Zinger into its new web development initiative. NanoMed's new website integrates Post Zinger to provide an intuitive content management system for updating the company's publications and online news room.

It also faciliates multiple subscriber options to the website's RSS feeds, access to archived data and email updates for users unfamiliar with RSS. "We are extremely pleased with the integration effort, design updates and functionality Castlock [now Post Zinger] provides," stated Stephen Benoit, CEO of NanoMed Pharmaceuticals.